Synthesis and anticancer and lipophilic properties of 10-dialkylaminobutynyl derivatives of 1,8- and 2,7-diazaphenothiazines

References

• Gupta RR, Kumar M. Synthesis, properties and reactions of phenothiazines. In: Gupta RR, ed. Phenothiazine and 1,4-benzothiazines – chemical and biological aspect. Amsterdam: Elsevier; 1988:1–161
   Google Scholar
• Silberg IA, Cormos G, Oniciu DC. Retrosynthetic approach to the synthesis of phenothiazines. In: Katritzky AR, ed. Advances in heterocyclic chemistry. New York: Elsevier; 2006:205
   Google Scholar
• Pluta K, Morak-Młodawska B, Jeleń M. Synthesis and properties of diaza-, triaza- and tetraazaphenothiazines. J Heterocycl Chem 2009;46:355–91
   Web of Science ®Google Scholar
• Pluta K, Morak-Młodawska B, Jeleń M. Recent progress in biological activities of synthesized phenothiazines. Eur J Med Chem 2011;46:3179–89
   PubMed Web of Science ®Google Scholar
• Motohashi N, Kawase M, Saito S, Sakagami H. Antitumor potential and possible targets of phenothiazine-related compounds. Curr Drug Targets 2000;1:237–45
   PubMedGoogle Scholar
• Motohashi N, Kawase M, Satoh K, Sakagami H. Cytotoxic potential of phenothiazines. Curr Drug Targets 2006;7:1055–66
   PubMed Web of Science ®Google Scholar
• Aaron JJ, Gaye Seye MD, Trajkovska S, Motohashi N. Bioactive phenothiazines and benzo[a]phenothiazines: spectroscopic studies and biological and biomedical properties and applications. Top Heterocycl Chem 2009;16:153–231
   Google Scholar
• Dasgupta A, Dastridara SG, Shirataki Y, Motohashi N. Antibacterial activity of artificial phenothiazines and isoflavones from plants. Top Heterocycl Chem 2008;15:67–132
   Google Scholar
• Sadandam YS, Shetty MM, Bhaskar Rao A. 10H-Phenothiazines: a new class of enzyme inhibitors for inflammatory diseases. Eur J Med Chem 2009;44:197–202
   PubMed Web of Science ®Google Scholar
• Amaral L, Kristiansen JE. Phenothiazines: potential management of Creutzfeldt-Jacob disease and its variants. Int J Antimicrob Agents 2001;18:411–17
   PubMed Web of Science ®Google Scholar
• Viveiros M, Martins M, Couto I, et al. The in vitro activity of phenothiazines against Mycobacterium avium: potential of thioridazine for therapy of the co-infected AIDS patient. In Vivo 2005;19:733–6
   PubMed Web of Science ®Google Scholar
• González-Muñoz GC, Arce MP, López B, et al. Acylamino-phenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer’s disease. Eur J Med Chem 2011;46:2224–35
   PubMed Web of Science ®Google Scholar
• Sudeshna G, Parimal K. Multiple non-psychiatric effects of phenothiazines: a review. Eur J Pharmacol 2010;648:6–14
   PubMed Web of Science ®Google Scholar
• Jaszczyszy A, Gąsiorowski K, Świątek P, et al. Chemical structure of phenothiazines and their biological activity. Pharmacol Rep 2012;64:16–23
   PubMed Web of Science ®Google Scholar
• Zong Z, Zielinska-Chomej K, Juntti T, et al. Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer. Cell Death Dis 2014;5:e1111
   PubMed Web of Science ®Google Scholar
• Schimler SD, Hall DJ, Debbert SL. Anticancer (hexacarbonyldocobalt)propargyl aryl ethers: synthesis, antiproliferative activity, apoptosis induction, and effct on cellular oxidative stress. J Inorg Biochem 2013;119:28–37
   PubMed Web of Science ®Google Scholar
• Kode NG, Phadtare S. Synthesis and cytotoxic activity of some new 2,6-substituted purines. Molecules 2011;16:5840–60
   PubMed Web of Science ®Google Scholar
• Boryczka S, Bębenek E, Wietrzyk J, et al. Synthesis, structure and cytotoxic activity of new acetylenic derivatives of betulin. Molecules 2013;18:4526–43
   PubMed Web of Science ®Google Scholar
• Piras S, Carta A, Briguglio I, et al. 2[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folateenzymes. Eur J Med Chem 2014;75:169–83
   PubMed Web of Science ®Google Scholar
• Zilla MK, Nayak D, Vishwakarma RA, et al. A convergent synthesis of alkyneeazide cycloaddition derivatives of 4-a,b-2-propyne podophyllotoxin depicting potent cytotoxic activity. Eur J Med Chem 2014;77:47–55
   PubMed Web of Science ®Google Scholar
• Ma K, Liu Y, Zhu Q, et al. H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S? PLoS One 2011;6:e20525
   PubMed Web of Science ®Google Scholar
• Romagnoli R, Baraldi PG, Cruz-Lopez O, et al. Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivatives. Bioorg Med Chem Lett 2011;21:2746–51
   PubMed Web of Science ®Google Scholar
• Xiao F, Xue Y, Luo Y, et al. Synthesis and cytotoxic activity of 7-alkynyl camptothecin derivatives. Chinese Chem Lett 2009;20:566–8
   Web of Science ®Google Scholar
• Vasilevsky SF, Govdi AI, Shults EE, et al. Efficient synthesis of the first betulonic acid-acetylene hybrids and their hepatoprotective and anti-inflammatory activity. Bioorg Med Chem 2009;17:5164–9
   PubMed Web of Science ®Google Scholar
• Al-Kaissi EN, Al-Ghrary NF, Al-Kaisi NK, et al. Synthesis and antimicrobial evaluation of 4,5-diaryl-2-[4-(tamino)-2-butynyl]-2,4-dihydro-3H-1,2,4-triazol-3-ones. Bioorg Med Chem Lett 2012;21:3390–5
   Web of Science ®Google Scholar
• Wube A, Guzman JD, Hüfner A, et al. Synthesis and antibacterial evaluation of a new series of N-alkyl-2-alkynyl/(E)-alkenyl-4-(1H)-quinolones. Molecules 2012;17:8217–40
   PubMed Web of Science ®Google Scholar
• Aly YL, Pedersen EB, La Colla P, Lodda R. Synthesis and anti-HIV-1 activity of new MKC-442 analogues with an alkynyl-substituted 6-benzyl group. Arch Pharm 2007;340:225–35
   PubMed Web of Science ®Google Scholar
• Cristofoli WA, Wiebe LI, De Clercq E, et al. 5Alkynyl analogs of arabinouridine and 2‘-deoxyuridine:  cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells. J Med Chem 2007;50:2851–7
   PubMed Web of Science ®Google Scholar
• Bräthe A, Andresen G, Gundersen LL, et al. Antioxidant activity of synthetic cytokinin analogues: 6-alkynyl- and 6-alkenylpurines as novel 15-lipoxygenase inhibitors. Bioorg Med Chem 2002;10:1581–6
   PubMed Web of Science ®Google Scholar
• Bisi A, Meli M, Gobbi S, et al. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives. Bioorg Med Chem 2008;16:6474–82
   PubMed Web of Science ®Google Scholar
• Rutkowska E, Pająk K, Jóźwiak K. Lipophilicity-methods of determination and its role in medicinal chemistry. Acta Pol Pharm 2013;70:13–18
   Web of Science ®Google Scholar
• Dąbrowska M, Komsta Ł, Krzek J, Kokoszka K. Lipophilic study of eight cephalosporins by reversed-phase thin-layer chromatographic method. Biomed Chromatogr 2015. [Epub ahead of print]. DOI: 10.1002/bmc.3490
   Web of Science ®Google Scholar
• Liu X, Testa B, Fahr A. Lipophilicity and its relationship with passive drug permeation. Pharm Res 2011;28:962–77
   PubMed Web of Science ®Google Scholar
• Arnot JA, Planey SL. The influence of lipophilicity in drug discovery and design. Expert Opin Drug Discov 2012;7:863–75
   PubMed Web of Science ®Google Scholar
• Waring MJ. Lipophilicity in drug discovery. Expert Opin Drug Discov 2010;5:235–48
   PubMed Web of Science ®Google Scholar
• Baguley BC, Finlay GJ. Derivatives of amsacrine: determinants required for high activity against Lewis lung carcinoma. J Natl Cancer Inst 1988;80:195–9
   PubMed Web of Science ®Google Scholar
• Facchetti I, Grandi M, Cucchi P, et al. Influence of lipophilicity on cytotoxicity of anthracyclines in LoVo and LoVo/Dx human cell lines. Anticancer Drug Des 1991;6:385–97
   PubMedGoogle Scholar
• Maliepaard M, de Mol NJ, Janssen LHM, et al. Role of lipophilicity in the in vitro antitumour activity of a series of new mitosene compounds. Anticancer Drug Des 1992;7:415–25
   PubMedGoogle Scholar
• Zimecki M, Artym J, Kocięba M, et al. The immunosuppressive activities of newly synthesized azaphenothiazines in human and mouse models. Cell Mol Biol Lett 2009;14:622–35
   PubMed Web of Science ®Google Scholar
• Pluta K, Jeleń M, Morak-Młodawska B, et al. Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank. Pharmacol Rep 2010;62:319–32
   PubMed Web of Science ®Google Scholar
• Morak-Młodawska B, Pluta K, Matralis AN, Kourounakis AP. Antioxidant activity of newly synthesized 2,7-diazaphenothiazines. Arch. Pharm. (Weinheim) 2010;343:268–73
   PubMed Web of Science ®Google Scholar
• Morak-Młodawska B, Pluta K, Zimecki M, et al. Synthesis and selected immunological properties of 10-substituted 1,8-diazaphenothiazines. Med Chem Res 2015;24:1408–18
   PubMed Web of Science ®Google Scholar
• Morak-Młodawska B, Pluta K. Acyl and sulfonyl derivatives of 10-aminoalkyl-2,7-diazaphenothiazines. Heterocycles 2009;78:1289–98
   Web of Science ®Google Scholar
• Morak-Młodawska B, Suwińska K, Pluta K, Jeleń M. 10-(Prop-2-yn-1-yl)-2,7-diazaphenothiazine. Acta Crystallogr Sect E Struct Rep Online 2012;68:o1590–1
   PubMedGoogle Scholar
• Mannhold R, Cruciani G, Dross K, Rekker R. Multivariate analysis of experimental and computational descriptors of molecular lipophilicity. J Comput Aided Mol Des 1998;12:573–81
   PubMed Web of Science ®Google Scholar
• Bodor N, Gabanyi Z, Wong CK. A new method for the estimation of partition coefficient. J Am Chem Soc 1989;111:3783–6
   Web of Science ®Google Scholar
• Hemann MT, Lowe SW. The p53-Bcl-2 connection. Cell Death Differ 2006;13:1256–9
   PubMed Web of Science ®Google Scholar
• Antonsson B, Montessuit S, Sanchez B, Martinou JC. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 2001;276:11615–23
   PubMed Web of Science ®Google Scholar
• Scorrano L, Korsmeyer SJ. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 2003;304:437–44
   PubMed Web of Science ®Google Scholar
• Antonsson B, Martinou JC. The Bcl-2 protein family. Exp Cell Res 2000;256:50–7
   PubMed Web of Science ®Google Scholar
• Völgyi G, Deák K, Válmos J, et al. RPTLC determination of log P of structurally diverse neutral compounds. J Planar Chromatogr 2008;21:143–9
   Web of Science ®Google Scholar
• Vaštag D, Perišić-Janjić N, Tomić J, Petrović S. Evaluation of the lipophilicity and prediction of biological activity of some N-cyclohexyl-N-substituted-2-phenylacetamide derivatives using RP-TLC. J Planar Chromatog 2011;24:435–40
   Web of Science ®Google Scholar
• Casoni D, Sârbu C. Comprehensive evaluation of lipophilicity of biogenic amines and related compounds using different chemically bonded phases and various descriptors. J Sep Sci 2012;35:915–21
   PubMed Web of Science ®Google Scholar
• Paszkowska J, Kania B, Wandzik I. Evaluation of the lipophilicity of selected uridine derivatives by use of RP-TLC, shake flask, and computational methods. J Liq Chromatogr Rel Technol 2012;35:1202–12
   Web of Science ®Google Scholar
• Mannhold R, Dross K. Calculation procedures for molecular lipophilicity: a comparative study. Quant Struct-Act Relat 1996;15:403–9
   Web of Science ®Google Scholar
• Franke U, Munk A, Wiese M. Ionisation constants and distribution coefficients of phenothiazines and calcium channel antagonists determined by a pH-metric method and correlation with calculated partition coefficients. J Pharm Sci 1999;88:89–95
   PubMed Web of Science ®Google Scholar
• Morak-Młodawska B, Pluta K, Jeleń M. Estimation of the lipophilicity of new anticancer and immunosuppressive 1,8-diazaphenothiazine derivatives. J Chromatogr Sci 2015;53:462–6
   PubMed Web of Science ®Google Scholar